Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With an acute shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.
In a statement, the MD and Chairman Dr. D Srinivasa Reddy had declared that Optimus pharma has internally developed the active pharmaceutical ingredient (API) and the formulations for the product and had obtained approval for conducting Phase 3 Clinical Trial.
As per the clinical trial protocol approved, 1218 subjects with mild COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with the standard of care, or standard of care alone. The treatment duration is a maximum of 05 days and the total study duration will be a maximum of 28 days from randomisation.
“Optimus is all geared to immediately begin manufacturing of Molnupiravir for COVID-19 patients in India. The interim results on 353 patients have shown promising results of Molnupiravir. The drug has been successful in reducing viral load effectively with RT-PCR negativity achieved 78.3 % in the test arm compared to 48.4% in the standard of care arm on Day 5. Day 10 and Day 14 of the treatment duration have also given excellent results wherein the remaining patients have successfully achieved RT-PCR negativity. The trial has also revealed clinical improvement in a significantly high proportion of patient’s health. The safety of the drug has also been established with no observed side effects, co-morbidity, or morbidity observed during and after the treatment duration,” Chairman & Managing Director – Dr. D Srinivasa Reddy said.
Optimus has approached the Drugs Controller General of India (DCGI) to seek Emergency Use Authorization for Molnupiravir in India.
Optimus Pharma is committed to serve the nation and fight back the pandemic to restore normalcy in the lives of people affected by COVID-19 at the earliest. With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.
Really fantastic information can be found on website.
There’s noticeably a bundle to know about this. I assume you made sure nice points in features also.
I think this is one of the so much important info for me. And i am satisfied studying your article. However should statement on few normal things, The website taste is ideal, the articles is really excellent : D. Just right task, cheers
I am so happy to read this. This is the type of manual that needs to be given and not the accidental misinformation that is at the other blogs. Appreciate your sharing this greatest doc.
I delight in, lead to I found just what I used to be having a look for. You’ve ended my 4 day lengthy hunt! God Bless you man. Have a great day. Bye
Wow, amazing blog layout! How long have you been blogging for? you made blogging look easy. The overall look of your web site is excellent, let alone the content!
It’s actually a cool and helpful piece of information. I’m happy that you just shared this useful info with us. Please keep us informed like this. Thanks for sharing.
I needed to compose you that little observation to help say thanks a lot over again with your exceptional secrets you have provided at this time. It was so extremely open-handed of people like you to give publicly just what some people would have offered for sale for an e book in making some profit for their own end, even more so seeing that you could have tried it if you desired. These advice additionally acted to be the good way to fully grasp that other people online have the same fervor similar to mine to understand a little more in respect of this issue. I am sure there are thousands of more fun moments ahead for individuals who see your site.
Some times its a pain in the ass to read what people wrote but this internet site is very user friendly! .
Thanks a lot for sharing this with all of us you actually know what you’re talking about! Bookmarked. Kindly also visit my site =). We could have a link exchange arrangement between us!